ESC Asia with APSC & AFC

A new analysis published by The Sage Group LLC concludes that the all-cause cost of critical limb ischemia (CLI) exceeds $200 billion in the United States.

The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced the 2020 Experiential Learning Program site visit proposal solicitation period. The 2020 Fall ELP submission period is open from Monday July 8, 2019 – Thursday, August 8, 2019, at 12 p.m. EST. The ELP is intended to provide a formal training mechanism for regulatory review staff to visit research, clinical, manufacturing and healthcare facilities to observe how medical devices are designed, developed and utilized.

Abbott has received U.S. Food and Drug Administration (FDA) approval for the most advanced MitraClip heart valve repair device to treat mitral regurgitation. The latest approval for the fourth-generation MitraClip device, MitraClip G4, puts new enhancements into the hands of physicians across the U.S. by delivering an expanded range of clip sizes, an alternative leaflet grasping feature and facilitation of procedure assessment in real time to offer doctors further options when treating mitral valve disease.

Elevated blood pressure and cholesterol levels in young adulthood may lead to an increased risk of heart disease later in life, regardless of later-in-life exposure to these risk factors, according to research published in the Journal of the American College of Cardiology.

NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-99) processing facility in Beloit, Wis., with equipment installation currently underway. Establishing this processing facility is part of NorthStar’s staged development and dual processing pathway approach to expanding current capacity and efficiencies in Mo-99 production.

Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The study demonstrated 73 percent single-procedure freedom from atrial fibrillation (AF) at 12 months with the use of Acutus' AcQMap advanced cardiac imaging and mapping system. Acutus develops electrophysiology (EP) technology solutions built into an open platform EP suite of products that enable personalized and adaptive approaches to therapy.

Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during use, which may add time to the procedure and compromises the safety of the patient.

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance imaging (MRI) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

Internet search engine giant Google unveiled a new Doodle on its homepage Friday, July 12, celebrating the life and work of cardiac surgeon Rene Favaloro. Favarolo, originally from Argentina, was one of the early pioneers of coronary artery bypass graft (CABG) surgery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now